Literature DB >> 3039958

Recurrent pleomorphic adenoma of the parotid.

W B Fleming.   

Abstract

Nineteen patients with recurrent pleomorphic adenoma of the parotid are reported. The aetiology of recurrence is discussed and capsule rupture is emphasized as a major cause, especially of multinodular recurrence. Further surgical attempts to remove recurrences are justified by the possibility of misdiagnosis of the original tumour and the late development of malignancy in recurrent nodules. Tumour clearance was achieved in all but two of 19 patients with recurrence or incomplete primary excision in those in whom it was attempted. Radiotherapy does not seem to be an appropriate alternative to repeated surgical excision.

Entities:  

Mesh:

Year:  1987        PMID: 3039958     DOI: 10.1111/j.1445-2197.1987.tb01329.x

Source DB:  PubMed          Journal:  Aust N Z J Surg        ISSN: 0004-8682


  5 in total

1.  Recurrent pleomorphic adenoma: uninodular versus multinodular disease.

Authors:  H Rowley; M Murphy; D Smyth; T P O'Dwyer
Journal:  Ir J Med Sci       Date:  2000 Jul-Sep       Impact factor: 1.568

2.  Dysregulation of the Rb pathway in recurrent pleomorphic adenoma of the salivary glands.

Authors:  Ana Amélia de Souza; Albina Altemani; Fabricio Passador-Santos; Cecilia Pedroso Turssi; Ney Soares de Araujo; Vera Cavalcanti de Araújo; Andresa Borges Soares
Journal:  Virchows Arch       Date:  2015-07-09       Impact factor: 4.064

3.  Pleomorphic adenoma of the submandibular gland: an evolving change in practice following review of a personal case series.

Authors:  Nazia Munir; Patrick J Bradley
Journal:  Eur Arch Otorhinolaryngol       Date:  2007-07-05       Impact factor: 2.503

4.  The surgical management of recurrent or residual pleomorphic adenomas of the parotid gland. Analysis and results in 40 patients.

Authors:  H Leverstein; R M Tiwari; G B Snow; J E van der Wal; I van der Waal
Journal:  Eur Arch Otorhinolaryngol       Date:  1997       Impact factor: 3.236

5.  Estrogen Receptor, Progesterone Receptor, and HER-2 Expression in Recurrent Pleomorphic Adenoma.

Authors:  Ana Amélia de Souza; Albina Altemani; Ney Soares de Araujo; Lucas Novaes Texeira; Vera Cavalcanti de Araújo; Andresa Borges Soares
Journal:  Clin Pathol       Date:  2019-09-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.